SMS Pharmaceuticals Ltd
Next 500 2018
+ 1 More
+ 1 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#463(2018)#470(2016)
#463(2018)#470(2016)
Financial Data 2024
Revenue
715
(INR Cr)
Net Operating Income
709
(INR Cr)
Assets
818
(INR Cr)
Profit
50
(INR Cr)
Net Worth
536
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 715 45.6% | 491 -23.0% | 638 18.1% | 540 25.5% | 430 -10.9% | 483 2.8% | 469 0.2% | 469 -25.0% | 625 3.1% | 606 19.9% | 505 54.3% | 328 43.1% | 229 -12.9% | 263 6.7% | 246 -1.2% | 249 - |
| Net Operating Income (INR Cr) | 709 35.86% | 522 0.42% | 520 -7.69% | 563 36.71% | 412 -11.39% | 465 0.48% | 463 5.60% | 438 -28.34% | 611 0.00% | 587 11.77% | 525 111.59% | 248 14.27% | 217 -5.50% | 230 -1.77% | 234 -3.03% | 241 16.38% |
| Profit (INR Cr) | 50 - | -7 - | 62 -0.5% | 63 98.1% | 32 -21.2% | 40 26.1% | 32 11.4% | 28 -30.3% | 41 16.0% | 35 72.9% | 20 -19.5% | 25 2121.1% | 1 -86.4% | 8 251.1% | 2 -62.1% | 6 - |
| Assets (INR Cr) | 818 14.3% | 716 -2.6% | 735 10.2% | 667 31.5% | 507 8.5% | 467 8.0% | 433 6.8% | 405 -19.2% | 501 18.1% | 424 7.0% | 396 -0.9% | 400 -6.9% | 429 5.2% | 408 8.3% | 377 7.8% | 349 - |
| Net Worth (INR Cr) | 536 16.5% | 461 -2.1% | 470 14.6% | 411 17.9% | 348 8.2% | 322 13.2% | 284 11.7% | 255 -13.2% | 294 0.0% | 255 14.9% | 222 -9.1% | 244 10.4% | 221 0.5% | 220 3.1% | 213 0.6% | 212 1.9% |
| Employee Cost (INR Cr) | 57 13.4% | 50 -1.8% | 51 23.9% | 41 4.6% | 39 10.6% | 36 8.5% | 33 21.8% | 27 -29.4% | 38 20.3% | 32 23.5% | 26 43.5% | 18 26.4% | 14 7.5% | 13 32.5% | 10 -2.5% | 10 - |
| Interest Cost (INR Cr) | 24 | 22 | 19 | 11 | 12 | 12 | 15 | 16 | 17 | 18 | 14 | 24 | 24 | 18 | 14 | 10 |
| Cash & Bank Balance (INR Cr) | 36 | 7 | 47 | 41 | 10 | 15 | 13 | 12 | 15 | 6 | 12 | 36 | 9 | 6 | 5 | 20 |
| Total Debt (INR Cr) | 281 | 254 | 263 | 255 | 157 | 144 | 146 | 149 | 204 | 167 | 167 | 149 | 207 | 187 | 163 | 137 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 7.0% | - | 9.8% | 11.6% | 7.3% | 8.3% | 6.8% | 6.1% | 6.6% | 5.8% | 4.0% | 7.7% | 0.5% | 3.2% | 1.0% | 2.5% |
| Profit As % Of Assets | 6.1% | - | 8.5% | 9.4% | 6.2% | 8.6% | 7.3% | 7.0% | 8.2% | 8.3% | 5.1% | 6.3% | 0.3% | 2.1% | 0.6% | 1.8% |
| Profit As % Of Networth | 9.3% | - | 13.2% | 15.2% | 9.1% | 12.4% | 11.2% | 11.2% | 13.9% | 13.8% | 9.2% | 10.4% | 0.5% | 3.8% | 1.1% | 3.0% |
| Interest Cost to EBITDA % | 20.2% | 40.3% | 16.7% | 9.2% | 15.4% | 13.2% | 16.6% | 21.1% | 19.2% | 20.8% | 24.3% | - | 64.1% | 46.0% | 77.9% | 48.5% |
| Debt to Equity Ratio | 0.52 | 0.55 | 0.56 | 0.62 | 0.45 | 0.45 | 0.51 | 0.59 | 0.70 | 0.65 | 0.75 | 0.61 | 0.94 | 0.85 | 0.77 | 0.65 |
| RONW | 9.9% | - | 15.4% | 16.1% | 9.8% | 13.7% | 15.0% | 13.0% | 14.2% | 14.8% | 8.8% | -27.8% | 0.5% | 3.9% | 1.1% | 3.0% |
| ROCE | 11.7% | 3.8% | 12.5% | 17.4% | 13.0% | 16.5% | 18.1% | 12.7% | 14.6% | 20.8% | 11.5% | -11.5% | 6.1% | 7.4% | 4.8% | 5.7% |